Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bellevue Life Sciences Ac...

    NASDAQ: BLAC · Real-Time Price · USD
    3.01
    -3.72 (-55.27%)
    At close: Feb 14, 2025, 3:53 PM

    Bellevue Life Sciences Acquisition Statistics

    Share Statistics

    Bellevue Life Sciences Acquisition has - shares outstanding. The number of shares has increased by -58.74% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 -58.74%

    Shares Change (QoQ)

    n/a
    		 -42.6%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 165,330

    FTD / Avg. Volume

    n/a
    		 1.08K%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 146.22 and the forward PE ratio is null. Bellevue Life Sciences Acquisition's PEG ratio is -0.08.

    PE Ratio

    n/a
    		 146.22

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.82

    P/FCF Ratio

    n/a
    		 -72.11

    PEG Ratio

    n/a
    		 -0.08
    Financial Ratio History

    Enterprise Valuation

    Bellevue Life Sciences Acquisition has an Enterprise Value (EV) of 59.03M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 62.49

    EV / EBIT

    n/a
    		 -72.09

    EV / FCF

    n/a
    		 -72.09

    Financial Position

    The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.01

    Quick Ratio

    n/a
    		 0.01

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 1.24% and Return on Invested Capital is -2.26%.

    Return on Equity

    n/a
    		 1.24%

    Return on Assets

    n/a
    		 1.1%

    Return on Invested Capital

    n/a
    		 -2.26%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 540.81K

    Effective Tax Rate

    n/a
    		 57.25%

    Stock Price Statistics

    The stock price has increased by -71.84% in the last 52 weeks. The beta is 0.53, so Bellevue Life Sciences Acquisition's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.53

    52-Week Price Change

    n/a
    		 -71.84%

    50-Day Moving Average

    n/a
    		 10.9

    200-Day Moving Average

    n/a
    		 10.89

    Relative Strength Index (RSI)

    n/a
    		 13

    Average Volume (20 Days)

    n/a
    		 15,258

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -1.83M

    Net Income

    n/a
    		 403.78K

    EBITDA

    n/a
    		 944.59K

    EBIT

    n/a
    		 944.59K

    Earnings Per Share (EPS)

    n/a
    		 0.07
    Full Income Statement

    Balance Sheet

    The company has 15.42K in cash and 0 in debt, giving a net cash position of 15.42K.

    Cash & Cash Equivalents

    n/a
    		 15.42K

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -3.91M

    Total Assets

    n/a
    		 20.93M

    Working Capital

    n/a
    		 -3.9M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -818.77K and capital expenditures -4, giving a free cash flow of -818.77K.

    Operating Cash Flow

    n/a
    		 -818.77K

    Capital Expenditures

    n/a
    		 -4

    Free Cash Flow

    n/a
    		 -818.77K

    FCF Per Share

    n/a
    		 -0.15
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BLAC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.68%

    FCF Yield

    n/a
    		 -1.39%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BLAC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.28

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist